about
Immunity against HIV/AIDS, malaria, and tuberculosis during co-infections with neglected infectious diseases: recommendations for the European Union research priorities.Role of 4-1BB receptor in the control played by CD8(+) T cells on IFN-gamma production by Mycobacterium tuberculosis antigen-specific CD4(+) T CellsThe role of tachykinins via NK1 receptors in progression of human gliomas.The M. tuberculosis phosphate-binding lipoproteins PstS1 and PstS3 induce Th1 and Th17 responses that are not associated with protection against M. tuberculosis infection.Constitutive expression of E- and P-selectin cognate ligands in human endothelial cellsB Cells and Programmed Death-Ligand 2 Signaling Are Required for Maximal Interferon-γ Recall Response by Splenic CD4⁺ Memory T Cells of Mice Vaccinated with Mycobacterium tuberculosis Ag85B.HIV-1 Tat protein vaccination in mice infected with Mycobacterium tuberculosis is safe, immunogenic and reduces bacterial lung pathology.Tachykinins and their receptors in human malignancies.Immunometabolic Pathways in BCG-Induced Trained Immunity.Correlation between binding characteristics and functional antagonism in human glioma cells by tachykinin NK1 receptor antagonists.Different susceptibility to neurokinin 1 receptor antagonists of substance P and septide-induced interleukin-6 release from U373 MG human astrocytoma cell line.Functional effects of a monoclonal antibody directed against a distinct epitope on 4F2 molecular complex in human peripheral blood mononuclear cell activation.The toll-like receptor 2/6 ligand MALP-2 reduces the viability of Mycobacterium tuberculosis in murine macrophagesMycobacterium tuberculosis PstS1 amplifies IFN-γ and induces IL-17/IL-22 responses by unrelated memory CD4+ T cells via dendritic cell activation.Point mutation increases a form of the NK1 receptor with high affinity for neurokinin A and B and septide.Immune response and protection by DNA vaccines expressing antigen 85B of Mycobacterium tuberculosis.The Ag85B protein of Mycobacterium tuberculosis may turn a protective immune response induced by Ag85B-DNA vaccine into a potent but non-protective Th1 immune response in mice.CD137 and CD137 ligand constitutively coexpressed on human T and B leukemia cells signal proliferation and survival.Cytotoxic effectors in human peripheral blood mononuclear cells induced by a mannoprotein complex of Candida albicans: a comparison with interleukin 2-activated killer cells.Microbial immunomodulators: mannoprotein constituents ofCandida albicans with immunomodulatory activity in lymphocyte cultures of normal, glioma-bearing and HIV-infected subjects.The LTK63 adjuvant improves protection conferred by Ag85B DNA-protein prime-boosting vaccination against Mycobacterium tuberculosis infection by dampening IFN-γ responseHuman and murine macrophages mediate activation of MEN 4901/T-0128: a new promising camptothecin analogue???polysaccharide conjugateEditorial [ Tachykinins and their Receptors in Human Physiology and Diseases Guest Editor: Carla Palma ]Neurokinin-1 Receptor Expression and Its Potential Effects on Tumor Growth in Human Pancreatic CancerEffect of the aromatase inhibitor, MEN 11066, on growth of two different MCF-7 sublinesCytotoxic and antitumor activity of MEN 10710, a novel alkylating derivative of distamycinGly166 in the NK1 receptor regulates tachykinin selectivity and receptor conformation 1Cell mediated cytotoxicity and cytokine production in peripheral blood mononuclear cells of glioma patientsProduction and characterisation of a monoclonal antibody to a cell-surface, glucomannoprotein constituent of Candida albicans and other pathogenic Candida species
P50
Q33346254-5DD4B72B-B321-49AD-8FF1-EC6515BB2C67Q33900380-8A8E723D-DAF1-4DFB-BA4D-B260180E0BBAQ33914886-87BC52A1-4359-41D0-8E9C-F89405430CEDQ34983762-8C4A690B-D36B-4C28-B509-BFAA222B05A7Q35609834-CDE5BCC6-B71F-4AC9-9E2D-85D5A169F297Q35778676-8D03930D-630F-40DC-B697-4320876C48DFQ36109585-68AC8595-DDDB-4474-841C-2E99504FE2F8Q36569907-FC3F40D3-16A3-46F1-A207-6940C377E450Q37525436-8D7D47F1-6476-4C4F-AAF9-8669B6E0347DQ40939405-3D1738C4-5A07-42B6-87EA-3EB9190C114AQ41473071-47A4C78B-5788-408B-BD4D-4C599286EF86Q41672665-B18388FD-757C-4308-8AD1-05C948CBBED6Q41965764-9FB83063-5A21-4262-AE6E-1C6CD8EC6089Q42261100-5B2034E2-30E9-4C9A-A30D-6F883210500BQ42567357-A4BEA1EA-3D8C-4CDA-83FC-47466391D94FQ42797817-B716F91D-44EB-4707-A18B-16349CA69DFEQ44831422-EE879B37-801F-41F1-B499-330514415E6DQ47348544-48A85680-3A71-4970-B547-F436C55F7CEFQ54350243-7C20E77F-36AA-4A28-A537-CAF3E84E11F6Q55484136-1216BA1F-E0C5-4B32-A435-A50903FFD000Q60441795-B020516D-F8E3-41B4-BA9B-22371D555BCFQ61454470-8197C4D1-8E24-41E6-9610-D98CC9931D36Q61454478-55E2230E-5EEA-45CF-B65F-EFCE6FD4FDDAQ61454482-6FED6C51-91C3-4FFF-B26C-A760BFBDD1DCQ61454488-49D9E2BF-421F-4CC2-9912-DF4BB74C4BA3Q61454502-66D51985-45C9-4601-AD7A-2FF4B4952EBEQ61454504-715DA14D-7643-49B9-B665-E362C81D07E1Q61454511-A7FE5A5B-983C-4F37-9C98-8E0CBDB41416Q61454548-1889BDD2-8872-4AE3-B98C-49DDBF26C5A2
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
C Palma
@ast
C Palma
@en
C Palma
@es
C Palma
@nl
C Palma
@sl
type
label
C Palma
@ast
C Palma
@en
C Palma
@es
C Palma
@nl
C Palma
@sl
prefLabel
C Palma
@ast
C Palma
@en
C Palma
@es
C Palma
@nl
C Palma
@sl
P106
P1153
7007004252
P31
P496
0000-0003-2583-5306